API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-publication-of-discovery-preclinical-and-phase-1-clinical-trial-results-of-ecnoglutide-xw003-in-molecular-metabolism-301873994.html
https://www.prnewswire.com/news-releases/sciwind-biosciences-to-highlight-positive-clinical-data-for-glp-1-peptide-agonist-ecnoglutide-xw003-at-the-american-diabetes-association-ada-83rd-annual-conference-301858192.html
https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-initiation-of-patient-dosing-in-phase-3-clinical-trials-of-ecnoglutide-xw003-a-long-acting-glp-1-analog-for-the-treatment-of-type-2-diabetes-in-china-301733145.html
https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-positive-interim-results-from-ongoing-phase-2b-clinical-trial-of-xw003-ecnoglutide-in-patients-with-obesity-301660847.html
https://www.prnewswire.com/news-releases/sciwind-biosciences-reports-positive-interim-results-from-phase-1c2a-clinical-trial-of-xw003-ecnoglutide-in-overweight-and-obese-adult-volunteers-in-china-301599771.html
https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-positive-topline-results-from-20-week-phase-2-clinical-trial-of-xw003-ecnoglutide-a-novel-long-lasting-glp-1-analogue-in-adult-patients-with-type-2-diabetes-in-china-301597462.html